[
    [
        {
            "time": "",
            "original_text": "【增减持】药明康德(02359.HK)获The Capital Group Companies增持7.09万股H股",
            "features": {
                "keywords": [
                    "药明康德",
                    "The Capital Group Companies",
                    "增持",
                    "H股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【增减持】药明康德(02359.HK)获The Capital Group Companies增持7.09万股H股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "中国医药行业研发专题分析报告:转型、创新、发展,中国医药研发蓬勃兴起,从2018年上市公司年报看国内医药研发",
            "features": {
                "keywords": [
                    "中国医药行业",
                    "研发",
                    "转型",
                    "创新",
                    "发展",
                    "2018年上市公司年报"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中国医药行业研发专题分析报告:转型、创新、发展,中国医药研发蓬勃兴起,从2018年上市公司年报看国内医药研发",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]